Mergers & Acquisitions

Filter

Current filters:

None

Popular Filters

28 to 52 of 921 results

India’s Competition Commission asks Sun Pharma to amend Ranbaxy takeover deal

India’s Competition Commission asks Sun Pharma to amend Ranbaxy takeover deal

17-11-2014

The Competition Commission has asked Indian generics company Sun Pharmaceutical Industries, which acquired…

GenericsIndiaMergers & AcquisitionsRanbaxy LaboratoriesSun Pharmaceutical

Valeant buys NicOx’ US ophthalmic diagnostics unit

17-11-2014

Ophthalmology-focused French biotech firm NicOx says that Canada’s Valeant Pharmaceuticals International…

BiotechnologyMergers & AcquisitionsNicOxOphthalmicsUSAValeant Pharmaceuticals InternationalVesneo

Reckitt Benckiser outlines plans for demerger of the RB Pharma business

17-11-2014

Following the announcement made by UK-based consumer goods giant Reckitt Benckiser that it was pursuing…

FinancialIndiviorMergers & AcquisitionsPharmaceuticalReckitt BenckiserReckitt Benckiser Pharmaceuticals

Recipharm acquires Portuguese CDMO

14-11-2014

Swedish pharmaceutical contract development and manufacturing organization, Recipharm AB has acquired…

LusomedicamentaMergers & AcquisitionsPharmaceuticalProductionRecipharm

Fresenius Kabi dumps planned Russian joint venture

09-11-2014

Fresenius Kabi and its partners Sistema JSFC and Zenitco Finance Management have mutually agreed to terminate…

BinnopharmFinancialFreseniusFresenius KabiMergers & AcquisitionsPharmaceuticalProductionRussia

Advent and Avista acquire UCB’s generics subsidiary Kremers Urban

Advent and Avista acquire UCB’s generics subsidiary Kremers Urban

07-11-2014

Global private equity investors Advent International and Avista Capital Partners have signed an agreement…

BelgiumGenericsKremers Urban PharmaceuticalsMergers & AcquisitionsUCB

Allergan is reportedly in takeover talks with Actavis

Allergan is reportedly in takeover talks with Actavis

07-11-2014

Botox maker Allergan is reportedly in merger talks with Ireland-headquartered generics major Actavis,…

ActavisAllerganMergers & AcquisitionsPharmaceuticalUSA

Perrigo expands in Europe with acquisition of Omega Pharma

06-11-2014

Health care company Perrigo has entered into a definitive agreement to acquire Belgium-based over-the-counter…

Mergers & AcquisitionsOmega PharmaPerrigoPharmaceutical

UPDATE: AstraZeneca divests Myalept for $325 million

06-11-2014

Anglo-Swedish pharma major AstraZeneca today announced that it has entered into a definitive agreement…

Aegerion PharmaceuticalsAstraZenecaMergers & AcquisitionsMyaleptPharmaceuticalRare diseases

MedImmune to acquire company to strengthen focus on biomarkers in immuno-oncology

MedImmune to acquire company to strengthen focus on biomarkers in immuno-oncology

04-11-2014

MedImmune, a US subsidiary of Anglo-Swedish pharma major AstraZeneca has entered into an agreement to…

AstraZenecaDefiniensMedImmuneMergers & AcquisitionsOncologyPharmaceutical

Bristol-Myers enters option agreement to acquire Danish firm

Bristol-Myers enters option agreement to acquire Danish firm

03-11-2014

US pharma major Bristol-Myers Squibb has entered into an exclusive option agreement to buy Denmark-based…

BiotechnologyBristol-Myers SquibbGalecto BiotechMergers & AcquisitionsRespiratory and PulmonaryTD139

Actinogen acquires Edinburgh BioQuarter spin-out Corticrine

Actinogen acquires Edinburgh BioQuarter spin-out Corticrine

31-10-2014

Australian biotech firm Actinogen has acquired Edinburgh BioQuarter spin-out, Corticrine.

ActinogenBiotechnologyCorticrineEdinburgh BioQuarterMergers & AcquisitionsNeurological

Bristol-Myers enters option deal to acquire F-star Alpha and FS102

28-10-2014

US pharma major Bristol-Myers Squibb has entered into an agreement that provides it with the exclusive…

BiotechnologyBristol-Myers SquibbF-star AlphaFS102Mergers & AcquisitionsOncology

Zogenix acquires UK-based Brabant Pharma for up to $130 million

28-10-2014

US CNS focused drugmaker Zogenix says it has acquired Brabant Pharma, a privately-held UK-based pharmaceutical…

BrabafenBrabant PharmaMergers & AcquisitionsNeurologicalPharmaceuticalZogenix

CSL buys Novartis’ influenza vaccines business for $275 million

CSL buys Novartis’ influenza vaccines business for $275 million

27-10-2014

Swiss pharma major Novartis has agreed to divest its influenza vaccines business to Australia’s CSL…

Anti-viralsbioCSLCSL LimitedFinancialMergers & AcquisitionsNovartisPharmaceuticalVaccines

Sutro Biopharma and Celgene expand accord; add buyout option

23-10-2014

Sutro Biopharma today announced it has entered into a strategic collaboration and option agreement with…

BiotechnologyCelgene Corp.LicensingMergers & AcquisitionsOncologySutro Biopharma

Mylan and Abbott amend terms of their $5.3 billion deal

Mylan and Abbott amend terms of their $5.3 billion deal

23-10-2014

US generic drugmaker Mylan and US drugmaker Abbott Laboratories have revised the pricing terms of their…

AbbottAbbott LaboratoriesGenericsMergers & AcquisitionsUSA

Actavis signs option to acquire relamorelin developer

Actavis signs option to acquire relamorelin developer

22-10-2014

Ireland-headquartered Actavis has been granted an exclusive option to acquire USA-based biopharma company…

ActavisDiabetesGastro-intestinalsIrelandMergers & AcquisitionsPharmaceuticalrelamorelinRhythm Health

MorphoSys gets milestone from Novartis; acquires new technology

21-10-2014

German company MorphoSys says it has received a milestone payment from Novartis in connection with the…

BiotechnologyLanthio PharmalanthipeptideMergers & AcquisitionsMorphoSysNovartisOphthalmicsResearch

Oriola-KD considering selling Russian business

21-10-2014

Finland’s Oriola-KD, a leading pharmaceutical retail and wholesale companies operating in Northern…

Mergers & AcquisitionsOriola-KDPharmaceuticalRussia

Valeant third-qtr profits beat expectations

20-10-2014

Canadian drugmaker Valeant Pharmaceuticals International has posted third-quarter 2014 financial results…

AllerganFinancialGenericsMergers & AcquisitionsValeant Pharmaceuticals International

Virax to acquire AKTivate and deep AKT inhibitor portfolio

17-10-2014

Australian biotechnology company Virax Holdings will acquire US oncology company AKTivate Therapeutics…

AKTivate TherapeuticsBiotechnologyMergers & AcquisitionsOncologyPathway OncologyVirax Holdings

28 to 52 of 921 results

Back to top